市場調查報告書

近視·老花眼治療的全球市場:到2028年預測

Global Myopia and Presbyopia Treatment Market Outlook 2028

出版商 Research Nester 商品編碼 937389
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
近視·老花眼治療的全球市場:到2028年預測 Global Myopia and Presbyopia Treatment Market Outlook 2028
出版日期: 2020年04月01日內容資訊: 英文 112 Pages
簡介

全球近視·老花眼治療市場從2021年∼2028年之間預計將以7.45%的年複合成長率增長,2028年達到178億3,674萬美元的規模。

本報告提供全球近視·老花眼治療市場的相關調查,提供市場規模和趨勢,成長及阻礙因素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 前提條件及簡稱

第3章 調查手法

第4章 摘要整理

第5章 市場動態分析

  • 成長要素
  • 阻礙因素
  • 市場趨勢

第6章 主要市場機會

第7章 產業風險分析

  • 需求風險分析
  • 供給風險分析

第8章 法規情形

第9章 新型冠狀病毒感染疾病的影響

第10章 市場展望

  • 市場規模·預測
    • 各金額
  • 市場區隔
    • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東及非洲

第11章 競爭結構

  • 詳細的概要
  • 競爭基準
  • 主要的提供產品的評估
  • 成長策略分析
  • 主要的合作·合資企業
  • 主要的合併和收購
  • 最近的新聞與開發
  • 主要的客戶與合作夥伴
  • 有關主要的金融指標的徹底分析
  • 企業簡介
    • Topcon Corporation (Japan)
    • ALCON
    • BAUSCH & LOMB INCORPORATED
    • Nidek Co. Ltd. (Japan)
    • CARL ZEISS AG
    • JOHNSON & JOHNSON VISION

第12章 策略性建議

目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

Myopia is a condition of the eye which is characterized by unclear vision while seeing objects at a distance while presbyopia is the condition where people are unable to clearly see the objects kept close to their eyes. The treatment products for both these conditions consist of eyeglasses, contact lenses, intra ocular lenses & LASIK surgery devices that improve the impaired visibility caused by myopia & presbyopia. The market for myopia and presbyopia treatment is anticipated to grow at a CAGR of 7.45% during the forecast period, i.e., 2021-2028. Further, the market accounted for a value of USD 17,836.74 million in 2019 which is predicted to reach a value of USD 34,058.64 million by the end of 2028.

The market for myopia and presbyopia treatment is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America held the leading share in global market in 2019 and is anticipated to continue this trend and hold the largest share of 36.12% in the market in 2028. This can be attributed to the increase in investments by government and private entities to maintain the highest quality of care offered at healthcare facilities. Myopia and presbyopia treatment market in Europe is primarily driven by the demand of these products by Germany, UK, France and Italy. The market is anticipated to reach a significantly high market size by 2028 as a result of rising availability of innovative treatment methods, particularly LASIK treatment which create this rise in demand for effective treatment products in the region. The market in Asia Pacific is projected to grow at the highest rate during the forecast period with a CAGR of 8.87% between 2021 and 2028 on account of growing advancements and innovations in the industry in countries such as China, Japan and India. The demand for myopia & presbyopia treatment products in Latin America is estimated to develop gradually over the forecast period and is presently capturing a limited market share in the global market with the market being led by the high demand in Brazil on account of changing consumer behaviour towards preventive health measures.

Some of the key industry leaders in the global myopia and presbyopia treatment market are: Topcon Corporation, Alcon, Bausch & Lomb Incorporated, Nidek Co., Ltd., Carl Zeiss AG and Johnson & Johnson Vision.

TABLE OF CONTENTS

1. INTRODUCTION

2. ASSUMPTIONS AND ACRONYMS

3. RESEARCH METHODOLOGY

4. EXECUTIVE SUMMARY - GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET

5. ANALYSIS OF MARKET DYNAMICS

  • 5.1. DRIVERS
  • 5.2. RESTRAINTS
  • 5.3. TRENDS

6. KEY MARKET OPPORTUNITIES

7. INDUSTRY RISK ANALYSIS

  • 7.1. DEMAND RISK ANALYSIS
  • 7.2. SUPPLY RISK ANALYSIS

8. REGULATORY LANDSCAPE

9. IMPACT OF COVID-19 ON MYOPIA & PRESBYOPIA TREATMENT

10. MYOPIA & PRESBYOPIA TREATMENT MARKET OUTLOOK

  • 10.1. MARKET SIZE AND FORECAST, 2018-2028
    • 10.1.1. BY VALUE (USD MILLION)
  • 10.2. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION, 2018-2028
    • 10.2.1. BY REGIONS
  • NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION)
  • MARKET SIZE, 2018-2028F (USD MILLION)
  • MARKET ANALYSIS
  • BY COUNTRY

ASSESSMENT OF MACROECONOMIC FACTORS

US & CANADA, 2018-2028F (USD MILLION)

  • EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION)
  • MARKET SIZE, 2018-2028F (USD MILLION)
  • MARKET ANALYSIS
  • BY COUNTRY

ASSESSMENT OF MACROECONOMIC FACTORS

UK & GERMANY, 2018-2028F (USD MILLION)

FRANCE & ITALY, 2018-2028F (USD MILLION)

SPAIN & RUSSIA, 2018-2028F (USD MILLION)

REST OF EUROPE, 2018-2028F (USD MILLION)

  • ASIA PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION)
  • MARKET SIZE, 2018-2028F (USD MILLION)
  • MARKET ANALYSIS
  • BY COUNTRY

ASSESSMENT OF MACROECONOMIC FACTORS

  • CHINA & INDIA, 2018-2028F (USD MILLION)
  • o JAPAN & SOUTH KOREA, 2018-2028F (USD MILLION)
  • o AUSTRALIA & MALAYSIA, 2018-2028F (USD MILLION)
  • o REST OF ASIA PACIFIC, 2018-2028F (USD MILLION)
  • LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION)
  • MARKET SIZE, 2018-2028F (USD MILLION)
  • MARKET ANALYSIS
  • BY COUNTRY
  • o ASSESSMENT OF MACROECONOMIC FACTORS
  • o BRAZIL & MEXICO, 2018-2028F (USD MILLION)
  • o REST OF LATIN AMERICA, 2018-2028F (USD MILLION)
  • MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION)
  • MARKET SIZE, 2018-2028F (USD MILLION)
  • MARKET ANALYSIS
  • BY COUNTRY
  • o ASSESSMENT OF MACROECONOMIC FACTORS
  • o UNITED ARAB EMIRATES & SAUDI ARABIA, 2018-2028F (USD MILLION)
  • o ISRAEL & SOUTH AFRICA, 2018-2028F (USD MILLION)
  • o REST OF MIDDLE EAST & AFRICA, 2018-2028F (USD MILLION)
  • 11. COMPETITIVE STRUCTURE
  • 11.1. DETAILED OVERVIEW
  • 11.2. COMPETITIVE BENCHMARKING
  • 11.3. ASSESSMENT OF KEY PRODUCT OFFERINGS
  • 11.4. ANALYSIS OF GROWTH STRATEGIES
  • 11.5. KEY COLLABORATIONS AND JOINT VENTURES
  • 11.6. KEY MERGERS AND ACQUISITIONS
  • 11.7. RECENT NEWS AND DEVELOPMENTS
  • 11.8. KEY CLIENTS AND PARTNERS
  • 11.9. EXHAUSTIVE ANALYSIS ON KEY FINANCIAL INDICATORS
  • 11.10. COMPANY PROFILES
  • 11.10.1. TOPCON CORPORATION
  • 11.10.2. ALCON
  • 11.10.3. BAUSCH & LOMB INCORPORATED
  • 11.10.4. NIDEK CO., LTD.
  • 11.10.5. CARL ZEISS AG
  • 11.10.6. JOHNSON & JOHNSON VISION
  • 12. STRATEGIC RECOMMENDATIONS